Jan 30, 2024, 15:45
Chiara Mercinelli: An honor to present Nure Combo trial at ASCO GU24
Chiara Mercinelli, Fellow Research Oncology Resident IRCCS San Raffaele, posted on X/Twitter:
“It has been an honor to present today Nure Combo trial at ASCO GU24. Great results with neoadjuvant nivolumab/abraxane followed by adjuvant nivolumab in MIBC, with 38.7% ypT0N0.”
Source: Chiara Mercinelli/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 1, 2024, 22:10
Dec 1, 2024, 22:10
Dec 1, 2024, 22:10
Dec 1, 2024, 22:10
Dec 1, 2024, 22:10
Dec 1, 2024, 22:10
Dec 1, 2024, 21:55
Dec 1, 2024, 21:26